These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18350595)

  • 21. Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival.
    Groeschl RT; Hong JC; Christians KK; Turaga KK; Tsai S; Pilgrim CH; Gamblin TC
    HPB (Oxford); 2013 Oct; 15(10):794-802. PubMed ID: 23782341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of virus-associated liver cancer in the Arab world, 1990-2010.
    Khan G; Hashim MJ
    Asian Pac J Cancer Prev; 2015; 16(1):265-70. PubMed ID: 25640363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma.
    Hiotis SP; Rahbari NN; Villanueva GA; Klegar E; Luan W; Wang Q; Yee HT
    BMC Gastroenterol; 2012 Jun; 12():64. PubMed ID: 22681852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma and hepatitis C in Mexico.
    Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM
    Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma.
    Desjardins LA
    Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C-associated hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Suwangool P; Mahachai V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S250-6. PubMed ID: 12929997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of patients with hepatitis B- or hepatitis C-based advanced-stage hepatocellular carcinoma.
    Carr BI; Guerra V; Steel JL; Lu SN
    Semin Oncol; 2015 Apr; 42(2):309-15. PubMed ID: 25843735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study.
    Goritsas CP; Athanasiadou A; Arvaniti A; Lampropoulou-Karatza C
    J Clin Gastroenterol; 1995 Apr; 20(3):220-4. PubMed ID: 7797831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries.
    Fattovich G
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1206-13. PubMed ID: 9730376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
    Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
    Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.